LFM-A13 is a BTK/PLK Inhibitor for Breast Cancer Research
Breast cancer is the most common cancer in women all over the world. Breast cancer development is associated with abnormal cell proliferation and defects in apoptosis. Noticeably, Polo-like Kinases (PLKs)…